FDA ‘breakthrough’ scheme approves GSK biologic, but is it faster?
The US Food and Drug Administration (FDA) has approved a second “Breakthrough Therapy” biologic but it is still unclear whether the programme speeds drugs to market, says an expert.
Archives for April 21, 2014
AbbVie inks Humira packaging deal as it launches in Saudi Arabia
AbbVie has teamed up with Arabio for the secondary packaging of its blockbuster biologic Humira as part of a launch into Saudi Arabian market.
Sanofi sells therapy cells: Aastrom buys products and plants
Aastrom Biosciences will pay Sanofi $6.5m (EUR4.7m) for its cell therapy business in a deal that gives the cash strapped regenerative medicines developer three commercial products.